Wellington Management Reports 11.5 Percent Stake in Celera | GenomeWeb

Wellington Management Reports 11.5 Percent Stake in Celera

May 12, 2008

NEW YORK (GenomeWeb News) – Boston-based investment advisor Wellington Management Company owns an 11.53 percent stake in Celera, according to a US Securities and Exchange Commission filing today.

According to the 13G/A filing, Wellington, in its capacity as an investment advisor, owns 9,094,951 shares on behalf of clients of the firm. It noted in the filing that “no such client is known to have such right of power with respect to more than five percent” of Celera’s common stock.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Spiders and Scorpions, Oh My!

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

Keep It Secret

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Page Joins Chronic Disease Startup

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

This Week in Cell

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.